⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LENZ News
LENZ Therapeutics, Inc. Common Stock
LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
globenewswire.com
LENZ
LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference
globenewswire.com
LENZ
LENZ Therapeutics, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
LENZ
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom
globenewswire.com
LENZ
Form 8-K
sec.gov
LENZ
LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
globenewswire.com
LENZ
GTC 2026 Live: This "Breathing" Glass Rack Reveals the Physical Form of Next-Gen AI Compute as an Intelligent Lifeform
prnewswire.com
NVDA
LENZ
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
globenewswire.com
LENZ
LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
globenewswire.com
LENZ
LENZ Therapeutics to Present at Upcoming Investor Conferences
globenewswire.com
LENZ